Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Invivyd Inc (IVVD)

Invivyd Inc (IVVD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Invivyd Inc 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 USA

https://invivyd.com Employees: 100 P: 781-819-0080

Sector:

Medical

Description:

INVIVYD INC. is a biopharmaceutical company. It involved in developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. INVIVYD INC., formerly known as Adagio Therapeutics, is based in WALTHAM, Mass.

Key Statistics

Overview:

Market Capitalization, $K 571,151
Enterprise Value, $K 501,801
Shares Outstanding, K 233,123
Float, K 173,910
% Float 74.60%
Short Interest, K 28,635
Short Float 12.28%
Days to Cover 6.86
Short Volume Ratio 0.50
% of Insider Shareholders 25.40%
% of Institutional Shareholders 70.36%

Financials:

Annual Sales, $ 25,380 K
Annual Net Income, $ -169,930 K
Last Quarter Sales, $ 13,130 K
Last Quarter Net Income, $ -10,470 K
EBIT, $ -62,230 K
EBITDA, $ -59,120 K

Growth:

1-Year Return 457.71%
3-Year Return 35.36%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 11/06/25
Next Earnings Date 03/19/26
Earnings Per Share ttm -0.47
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year 88.24%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IVVD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -92.97%
Return-on-Assets % -51.88%
Profit Margin % -669.54%
Debt/Equity 0.00
Price/Sales 6.49
Price/Cash Flow N/A
Price/Book 6.11
Book Value/Share 0.40
Interest Coverage -1.68
60-Month Beta 0.61
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar